JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
iShares MSCI Singapore ETF
EWS
$1.42B
| $37.4M | ﹤0.01% |
1,883,206
+507,660
| +37% | +$9.9M |
2013 Q2
39 quarters
|
|
1227
Watsco Inc
WSO
$12.3B
| $37.3M | ﹤0.01% |
117,372
+55,033
| +88% | +$16.2M |
2013 Q2
39 quarters
|
|
1228
Open Text
OTEX
$5.38B
| $37.3M | ﹤0.01% |
967,282
-212,703
| -18% | -$7.35M |
2015 Q4
29 quarters
|
|
1229
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.59B
| $37.3M | ﹤0.01% |
1,500,267
+376,561
| +34% | +$9.28M |
2013 Q2
39 quarters
|
|
1230
OGE Energy
OGE
$9.37B
| $37.2M | ﹤0.01% |
986,717
+123,079
| +14% | +$4.63M |
2013 Q2
39 quarters
|
|
1231
iShares TIPS Bond ETF
TIP
$14.4B
| $37.1M | ﹤0.01% |
336,947
-323,439
| -49% | -$35M |
2013 Q2
39 quarters
|
|
1232
Targa Resources
TRGP
$60.4B
| $37.1M | ﹤0.01% |
508,464
+55,636
| +12% | +$4.1M |
2013 Q2
39 quarters
|
|
1233
PUT
MetLife
MET
$60B
| $37.1M | ﹤0.01% |
640,100
-216,100
| -25% | -$14.6M |
2021 Q2
7 quarters
|
|
1234
Signet Jewelers
SIG
$3.85B
| $36.9M | ﹤0.01% |
474,410
+55,128
| +13% | +$4.09M |
2013 Q2
39 quarters
|
|
1235
Omega Healthcare
OHI
$13.9B
| $36.6M | ﹤0.01% |
1,333,428
+296,932
| +29% | +$8.26M |
2013 Q2
39 quarters
|
|
1236
Super Micro Computer
SMCI
$28.7B
| $36.5M | ﹤0.01% |
3,421,540
+346,570
| +11% | +$3.13M |
2020 Q1
12 quarters
|
|
1237
iShares US Home Construction ETF
ITB
$2.34B
| $36.4M | ﹤0.01% |
518,531
+129,801
| +33% | +$8.77M |
2013 Q2
39 quarters
|
|
1238
Charles River Laboratories
CRL
$13.9B
| $36.4M | ﹤0.01% |
180,386
+43,786
| +32% | +$9.92M |
2013 Q2
39 quarters
|
|
1239
Nasdaq
NDAQ
$50.5B
| $36.1M | ﹤0.01% |
660,844
+87,352
| +15% | +$5.05M |
2013 Q2
39 quarters
|
|
1240
OFG Bancorp
OFG
$2.17B
| $36M | ﹤0.01% |
1,442,422
+68,968
| +5% | +$1.93M |
2013 Q2
39 quarters
|
|
1241
Cleveland-Cliffs
CLF
$6.46B
| $36M | ﹤0.01% |
1,961,714
+613,805
| +46% | +$12.2M |
2013 Q2
39 quarters
|
|
1242
argenx
ARGX
$57.5B
| $35.9M | ﹤0.01% |
96,283
+45,712
| +90% | +$16.9M |
2020 Q3
10 quarters
|
|
1243
TORM
TRMD
$4.11B
| $35.9M | ﹤0.01% |
1,151,619
+683,159
| +146% | +$20.8M |
2022 Q1
4 quarters
|
|
1244
PUT
Deutsche Bank
DB
$65.7B
| $35.8M | ﹤0.01% |
3,511,000
+2,377,300
| +210% | +$28.4M |
2022 Q1
4 quarters
|
|
1245
PUT
Lowe's Companies
LOW
$101B
| $35.8M | ﹤0.01% |
179,200
-26,800
| -13% | -$5.44M |
2017 Q1
24 quarters
|
|
|
PCH
1246
DELISTED
PotlatchDeltic
PCH
| $35.8M | ﹤0.01% |
723,256
+57,103
| +9% | +$2.68M |
2013 Q2
39 quarters
|
|
1247
Principal Financial Group
PFG
$24B
| $35.8M | ﹤0.01% |
481,562
+63,123
| +15% | +$5.36M |
2013 Q2
39 quarters
|
|
1248
Sprout Social
SPT
$611M
| $35.7M | ﹤0.01% |
587,112
+46,744
| +9% | +$2.86M |
2020 Q1
12 quarters
|
|
1249
ArcBest
ARCB
$2.96B
| $35.7M | ﹤0.01% |
386,645
-109,978
| -22% | -$9.89M |
2013 Q2
39 quarters
|
|
1250
Clean Harbors
CLH
$16.8B
| $35.7M | ﹤0.01% |
250,106
+28,506
| +13% | +$3.71M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.